Page last updated: 2024-12-07

acid violet 17

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

violet BNP: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92205
SCHEMBL ID1395972
MeSH IDM0099404

Synonyms (75)

Synonym
pontacyl violet c4bn
metamine fast violet 4b
tertracid milling violet 4b
brilliant acid violet 4b
sumitomo acid violet 5bn
violet 2embl
fast acid violet b
formyl violet s4b
acidal brilliant violet 2b
coomassie violet r
brilliant milling violet s4b
leather violet s4b
formyl violet
mitsui acid violet 5bn
hispacid violet x4bf
coomassie lake violet r
c.i. acid violet 17, sodium salt
acid leather violet b
airedale violet 4bns
adc acid brilliant milling violet 4bs
c.i. food violet 1
acid violet acs
solar violet 4bn
pontacyl violet s4b
c.i. 42650
acidal brilliant violet 6b
cetil brilliant violet s4b
calcocid violet 4bxn
acid violet 4bo
acid leather violet 2b
naphthalene leather violet r
acid violet 17
milling violet s4b
erio violet 6bn
4129-84-4
burmese violet 4bo
1942 violet
c.i. acid violet 17
acid violet 5bs
shimazaki acid violet 5bn
violet s4r
derma violet 4br
violet bnp
amacid violet 3b
food violet 1
pontacyl violet c4b
formyl violet s4ba
vondamol violet s4b
acid leather violet 3b
merantine violet s4b
fenazo violet x4b
coomassie violet r200, dye content 50 %
einecs 223-942-6
nsc 5019
nsc 71963
benzenemethanaminium, n-(4-((4-(diethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, inner salt, sodium salt (1:1)
hydrogen (4-((4-(diethylamino)phenyl)(4-(ethyl(3-sulphonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)(ethyl)(3-sulphonatobenzyl)ammonium, sodium salt
c.i.42581
benzenemethanaminium, n-(4-((4-(diethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt
benzenemethanaminium, n-(4-((4-(diethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, inner salt, sodium salt
AKOS015916401
benzenemethanaminium, n-[4-[[4-(diethylamino)phenyl][4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-n-ethyl-3-sulfo-, inner salt, sodium salt
SCHEMBL1395972
acidviolet17
hydrogen [4-[[4-(diethylamino)phenyl][4-[ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulp honatobenzyl)ammonium na salt
W-109953
DTXSID1041635
acid violet 17 (c.i. 42650)
mfcd00012120
sodium (z)-3-(((4-((4-(diethylamino)phenyl)(4-(ethyl(3-sulfonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dienylidene)(ethyl)ammonio)methyl)benzenesulfonate
benzenemethanaminium, n-(4-((4-(diethylamino)phenyl)(4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-n-ethyl-3-sulfo-, hydroxide, inner salt, sodium salt (9ci)
sodium;3-[[4-[[4-(diethylamino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]-n-ethylanilino]methyl]benzenesulfonate
serva violet 17
1313437-37-4
sodium 3-(((4-((4-(diethylamino)phenyl)(4-(ethyl(3-sulfonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)(ethyl)ammonio)methyl)benzenesulfonate

Research Excerpts

Effects

ExcerptReferenceRelevance
"Acid violet 17 (AV17) has recently received CE certification as a dye for intraocular use during vitreoretinal interventions. "( Acid Violet 17: a New Dye for Chromovitrectomy?
Gerding, H, 2016
)
3.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (15.79)18.7374
1990's1 (5.26)18.2507
2000's6 (31.58)29.6817
2010's9 (47.37)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.92 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]